JPRN-UMIN000014929已完成未知
The efficacy of topical NSAIDs for anti-VEGF therapy for vitreomacular disease - The efficacy of topical NSAID
TT East japan Tohoku Hospital0 个研究点目标入组 200 人开始时间: 2014年8月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •macular ischemia ocular inflammation systemic disorder other than hypertension and hypercholesterolaemia
研究者
相似试验
进行中（未招募）
1 期
How Effective are Topical NSAIDs in the Treatment of Hip Osteoarthritis: An In Vivo Study in Patients Undergoing Total Hip Arthroplasty.Osteoarthritis of the hipMedDRA version: 19.1Level: LLTClassification code 10031167Term: Osteoarthritis NOSSystem Organ Class: 100000004859EUCTR2017-000178-13-GBRoyal Bournemouth and Christchurch Hospitals NHS Foundation Trust12
已完成
不适用
Clinical study in new protocol of anti-VEGF agents for macular edema with retinal vein occlusion and in relation between the protocol and cytokinesRetinal Vein OcclusionJPRN-UMIN000030311Tokyo medical university100
已完成
不适用
Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucomaISRCTN12125882Horten Center, University of Zurich (Switzerland)50
招募中
不适用
The effect of anti-VEGF treatments for neovascular,exudative and inflammatory ocular diseasesOcular diseases including neovascular, serous and inflammatory diseasesJPRN-UMIN000021589The department of ophthalmology,Tohoku university graduate School of Medicine3,000
尚未招募
不适用
Evaluation of the responsiveness of anti-VEGF treatment in DMEdiabetic retinopathy (DR)NL-OMON29053GSMS70